150 related articles for article (PubMed ID: 7324949)
1. Evaluation of a new sustained-release theophylline tablet for children.
Selvig K; Alme A; Rugstad HE; Aas K; Bjerve KS
Acta Paediatr Scand; 1981 Nov; 70(6):929-33. PubMed ID: 7324949
[TBL] [Abstract][Full Text] [Related]
2. Comparison of steady state serum theophylline concentrations in healthy volunteers after dosing with Euphyllin retard and PulmiDur.
Karlsson S; Lührmann B; Bahner ML; Schulz HU
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):342-6. PubMed ID: 3623739
[TBL] [Abstract][Full Text] [Related]
3. Influence of food on the absorption rate and bioavailability of a sustained release theophylline preparation.
Pedersen S; Moeller-Petersen J
Allergy; 1982 Oct; 37(7):531-4. PubMed ID: 7181050
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
5. Serum theophylline levels in young children receiving a sustained-release theophylline tablet.
Howard ML; Baldwin JN; Kobayashi RH; Jensen BK
J Asthma; 1984; 21(5):299-303. PubMed ID: 6501169
[TBL] [Abstract][Full Text] [Related]
6. Serum theophylline levels in asthmatic children receiving sustained-release theophylline tablets.
Kelly HW; Murphy S
Am J Hosp Pharm; 1979 Dec; 36(12):1698-701. PubMed ID: 525646
[TBL] [Abstract][Full Text] [Related]
7. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
Beer S; Laver J; Benson L; Cotariu D; Neli P; Saidman JL; Viure E
Isr J Med Sci; 1982 Feb; 18(2):255-8. PubMed ID: 7068356
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of long-term oral administration of a sustained release theophylline preparation in children with chronic asthma.
Cantani A; Businco E; Businco L; Solano A; Calabretta C
Allergol Immunopathol (Madr); 1983; 11(1):11-4. PubMed ID: 6858803
[TBL] [Abstract][Full Text] [Related]
9. The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets.
Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Thürkow-Luikens AJ
Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):506-10. PubMed ID: 6500770
[TBL] [Abstract][Full Text] [Related]
10. Serum profile and bioavailability of a controlled-release theophylline formulation for once-daily use: comparison with a 12-hr preparation.
Cohen BM
J Asthma; 1984; 21(5):305-9. PubMed ID: 6389484
[TBL] [Abstract][Full Text] [Related]
11. Comparative bio-availability of theophylline whole and halved sustained-release tablets.
Müller FO; Hundt HK; Luus HG; van Dyk M; Groenewoud G; van der Meer MJ; Steinijans VW
S Afr Med J; 1987 Aug; 72(3):175-8. PubMed ID: 3299763
[TBL] [Abstract][Full Text] [Related]
12. Absorption characteristics of once-a-day slow-release theophylline preparation in children with asthma.
Pedersen S; Steffensen G
J Pediatr; 1987 Jun; 110(6):953-9. PubMed ID: 3585612
[TBL] [Abstract][Full Text] [Related]
13. A new sustained-release theophylline suspension for asthmatic children: evaluation of serum theophylline concentrations.
Boner AL; Vallone G; Valletta E; Bernocchi D; Plebani M
Int J Clin Pharmacol Res; 1987; 7(5):345-50. PubMed ID: 3667007
[TBL] [Abstract][Full Text] [Related]
14. Relationship of formulation and dosing interval to fluctuation of serum theophylline concentration in children with chronic asthma.
Weinberger M; Hendeles L; Wong L
J Pediatr; 1981 Jul; 99(1):145-52. PubMed ID: 7252652
[TBL] [Abstract][Full Text] [Related]
15. Inconsistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children.
Rogers RJ; Kalisker A; Wiener MB; Szefler SJ
J Pediatr; 1985 Mar; 106(3):496-501. PubMed ID: 3973788
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of circadian variation of serum theophylline concentration and bioavailability between Theo-dur tablet and a new sustained-release theophylline formulation (E-0686 granule)].
Kishida M; Okuma M; Uekusa T; Akimoto K; Obata T; Akazawa A; Odajima Y; Nagakura T; Iikura Y; Hukushima K
Arerugi; 1988 Apr; 37(4):218-25. PubMed ID: 3228360
[No Abstract] [Full Text] [Related]
17. The relation of product formulation to absorption of oral theophylline.
Weinberger M; Hendeles L; Bighley L
N Engl J Med; 1978 Oct; 299(16):852-7. PubMed ID: 692577
[TBL] [Abstract][Full Text] [Related]
18. Effect of food on the bioavailability and pattern of release of a sustained-release theophylline tablet.
Leeds NH; Gal P; Purohit AA; Walter JB
J Clin Pharmacol; 1982 Apr; 22(4):196-200. PubMed ID: 7096605
[TBL] [Abstract][Full Text] [Related]
19. Theophylline concentrations in serum and saliva after oral microcrystalline and sustained-release preparations in asthmatics.
Munch EP; Søndergaard I; Weeke B
Allergy; 1981 Feb; 36(2):89-98. PubMed ID: 7235205
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM
Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
